European Cannabis Market Research Report 2022: Unlicensed Medical Cannabis Sales and Projected Sales of Adult Use Cannabis in Europe

DUBLIN, April 25, 2022 /PRNewswire/ -- The "European Cannabis Report with Market Sizing Data & Adult-Use Cannabis Supplement" report has been added to ResearchAndMarkets.com's offering.

2021 was another huge year for the liberalisation and mainstreaming of cannabis in Europe.

Legislation, regulations and market developments continued to evolve for the better. Many countries continued to improve their medical cannabis access schemes, and the publisher estimates that €354 million worth of unlicensed medical cannabis will be sold in Europe in 2022, and this could reach to €2.3 billion in 2026.

CBD products are continuing their path towards recognition as fully-legal consumer packaged goods (CPGs). As of 2022, several novel foods applications for CBD have been validated by the European Commission.

But, the story which is drawing most international attention is the upcoming liberalisation of adult-use cannabis in Europe, with the ruling coalition of Germany promising full legalisation and commercialisation of adult-use cannabis in this legislative term. Legal sales are set to start in Switzerland by the end of 2022 followed shortly by those in the Netherlands.

Key Topics Covered:

Market Sizing

  • Unlicensed Medical Cannabis Sales in Europe
  • Projected Sales of Adult Use Cannabis in Europe
  • CBD Sales in Europe
  • Country Focus

Expert Interviews

  • Benedikt Sons, Cansativa Group
  • Jakob Sons, Cansativa Group
  • Timo Bongartz, Fluence EMEA
  • Dr Anne Schlag, Project Twenty21
  • Bek Muslimov & Nikolay Tretiyakov, Leafy Tunnel
  • Denise Fatischek, Tilray

CBD

  • Fragmented European Markets
  • CBD Legislation in Europe
  • CBD as a Cosmetic
  • CBD as a Medicine
  • Ingestible CBD
  • CBD Flowers

Trends

  • Medical Cannabis Pilot Trials
  • Supply Chain
  • Product Shortages in Europe
  • Countries Allowing Cultivation in Europe
  • Patients and Products
  • Expert Interviews

Country Focus

  • Germany
  • Italy
  • The Netherlands
  • Poland
  • United Kingdom
  • Switzerland
  • Czechoslovakia

Companies Mentioned

  • 4C Labs
  • Brains Bio
  • Canna-X
  • Cannabis Europa
  • Cannavigia
  • Cansativa Group
  • Cantourage
  • CBDepot.eu
  • Fluence
  • Linnea
  • MGC Pharma
  • Perfect Plants
  • SOMAI Pharmaceuticals
  • Storz & Bickel

For more information about this report visit https://www.researchandmarkets.com/r/ctabgo

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/european-cannabis-market-research-report-2022-unlicensed-medical-cannabis-sales-and-projected-sales-of-adult-use-cannabis-in-europe-301531978.html

SOURCE Research and Markets

Posted In: Publishing/Information ServicesPress Releases

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.